WallStreetZenWallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17784$295.43
$231.62kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17360$298.09
$107.31kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17240$296.30
$71.11kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17240$299.58
$71.90kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-1716$301.13
$4.82kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-17360$294.52
$106.03kSell
Bastiano SannaEVP Cell Genetic Therapies2023-03-16264$301.07
$79.48kSell
Bastiano SannaEVP Cell Genetic Therapies2023-03-162,482$300.54
$745.94kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-13420$292.41
$122.81kSell
Charles F. Wagner Jr.EVP Chief Financial Officer2023-03-131,153$293.35
$338.23kSell

1 of 37

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.43%24,241,437$7.25BInstitution
Vanguard Group Inc8.38%21,546,903$6.44BInstitution
Fmr LLC6.95%17,866,291$5.34BInstitution
Capital World Investors4.97%12,769,006$3.82BInstitution
State Street Corp4.81%12,370,430$3.70BInstitution
Alliancebernstein LP3.53%9,069,580$2.71BInstitution
Wellington Management Group LLP2.66%6,827,583$2.04BInstitution
Jpmorgan Chase Co2.14%5,490,408$1.64BInstitution
Geode Capital Management LLC2.09%5,382,719$1.61BInstitution
Jennison Associates LLC1.99%5,115,540$1.53BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX91.63%1.52%Net SellingNet Selling
REGN69.97%30.03%Net SellingNet Selling
MRNA64.14%22.31%Net SellingNet Selling
SGEN46.23%53.77%Net SellingNet Selling
BNTX16.32%0.00%
View Top Biotech Stocks

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 91.63% institutional shareholders, 1.52% Vertex Pharmaceuticals insiders, and 6.85% retail investors. Blackrock Inc is the largest individual Vertex Pharmaceuticals shareholder, owning 24.24M shares representing 9.43% of the company. Blackrock Inc's Vertex Pharmaceuticals shares are currently valued at $7.25B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.